HELLS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.209000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.817200E-01
Normal-vs-Stage2
5.531800E-01
Normal-vs-Stage3
9.566400E-01
Normal-vs-Stage4
7.979600E-01
Stage1-vs-Stage2
3.824600E-01
Stage1-vs-Stage3
9.220400E-01
Stage1-vs-Stage4
7.168400E-01
Stage2-vs-Stage3
5.519600E-01
Stage2-vs-Stage4
7.961800E-01
Stage3-vs-Stage4
8.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.092200E-01
Normal-vs-AfricanAmerican
7.514400E-01
Normal-vs-Asian
5.789600E-01
Caucasian-vs-AfricanAmerican
2.576200E-01
Caucasian-vs-Asian
7.086800E-01
AfricanAmerican-vs-Asian
2.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.698000E-01
Normal-vs-Female
5.721800E-01
Male-vs-Female
6.327000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.706400E-01
Normal-vs-Age(41-60Yrs)
5.518600E-01
Normal-vs-Age(61-80Yrs)
6.499200E-01
Normal-vs-Age(81-100Yrs)
7.115600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.910200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.673600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.085200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.681200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.052600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.239400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.979600E-01
Normal-vs-Daily Drinker
6.910600E-01
Normal-vs-Weekly Drinker
4.977600E-01
Normal-vs-Occasional Drinker
4.519800E-01
Normal-vs-Social Drinker
7.622000E-01
Non Drinker-vs-Daily Drinker
7.384000E-01
Non Drinker-vs-Weekly Drinker
8.112800E-01
Non Drinker-vs-Occasional Drinker
7.039600E-01
Non Drinker-vs-Social Drinker
6.039800E-01
Daily Drinker-vs-Weekly Drinker
5.951000E-01
Daily Drinker-vs-Occasional Drinker
4.901600E-01
Daily Drinker-vs-Social Drinker
8.276800E-01
Weekly Drinker-vs-Occasional Drinker
9.139000E-01
Weekly Drinker-vs-Social Drinker
4.729600E-01
Occasional Drinker-vs-Social Drinker
3.846200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.288000E-01
Normal-vs-Grade 2
7.300000E-01
Normal-vs-Grade 3
4.741200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.422800E-03
Grade 1-vs-Grade 3
1.999570E-04
Grade 1-vs-Grade 4
6.288000E-01
Grade 2-vs-Grade 3
9.792100E-02
Grade 2-vs-Grade 4
7.300000E-01
Grade 3-vs-Grade 4
4.741200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.470800E-01
Normal-vs-NonDiabetic
5.746800E-01
Diabetic-vs-NonDiabetic
2.382800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.718600E-01
Normal-vs-NoPancreatitis
6.651000E-01
Pancreatitis-vs-NoPancreatitis
2.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.554800E-01
Normal-vs-N1
5.744200E-01
N0-vs-N1
6.197600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.194450E-01
Normal-vs-TP53-NonMutant
7.411400E-01
TP53-Mutant-vs-TP53-NonMutant
2.06810000002999E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
